Nadia Traficante

机构：The University of Melbourne, Peter MacCallum Cancer Centre · ORCID：0000-0001-7459-8576

发表论文 284 篇 · 总被引 21164 次 · h-index 47

代表论文

Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer (2024 · Journal of Clinical Investigation · 被引 20)
Demethylating agents drive PARP inhibitor resistance in ovarian carcinomas with BRCA1 gene silencing (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)
Using Polygenic Risk Scores to Refine Risk and Outcomes in High-grade Serous Ovarian Cancer in Australia (2026 · Cancer Epidemiology Biomarkers & Prevention)
Real-world comparative outcomes of neoadjuvant chemotherapy with interval cytoreductive surgery versus primary cytoreductive surgery in epithelial ovarian cancer: insights from the australian ovarian cancer study (AOCS) (2026 · International Journal of Gynecological Cancer)
Supplementary Figure 2 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma (2025)
Supplementary Table 1 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma (2025)